Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

A randomized, double-blind Phase 2/3 trial evaluating Azeliragon for safety and effectiveness in patients hospitalized with COVID-19 (and pneumonia), currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Azeliragon (Azeliragon)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: COVID-19 | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING